These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21596202)

  • 1. The prevalence of restless legs syndrome in adult Saudis attending primary health care.
    BaHammam A; Al-shahrani K; Al-zahrani S; Al-shammari A; Al-amri N; Sharif M
    Gen Hosp Psychiatry; 2011; 33(2):102-6. PubMed ID: 21596202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and clinical features of restless legs syndrome: a door to door population study in Orhangazi, Bursa in Turkey.
    Erer S; Karli N; Zarifoglu M; Ozcakir A; Yildiz D
    Neurol India; 2009; 57(6):729-33. PubMed ID: 20139500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of restless legs syndrome in the rural town of Cassia dos Coqueiros in Brazil.
    Eckeli AL; Gitaí LL; Dach F; Ceretta H; Sander HH; Passos AD; do Prado GF; Fernandes RM
    Sleep Med; 2011 Sep; 12(8):762-7. PubMed ID: 21824818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restless legs syndrome in end-stage renal disease.
    Gigli GL; Adorati M; Dolso P; Piani A; Valente M; Brotini S; Budai R
    Sleep Med; 2004 May; 5(3):309-15. PubMed ID: 15165541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: Prevalence and characteristics.
    Allen RP; Stillman P; Myers AJ
    Sleep Med; 2010 Jan; 11(1):31-7. PubMed ID: 19464949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency, severity and risk factors for restless legs syndrome in healthcare personnel.
    Civi S; Kutlu R; Tokgoz S
    Neurosciences (Riyadh); 2012 Jul; 17(3):230-5. PubMed ID: 22772928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restless legs syndrome in patients on dialysis.
    Al-Jahdali HH; Al-Qadhi WA; Khogeer HA; Al-Hejaili FF; Al-Ghamdi SM; Al Sayyari AA
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):378-85. PubMed ID: 19414938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome in an Indian urban population.
    Rangarajan S; Rangarajan S; D'Souza GA
    Sleep Med; 2007 Dec; 9(1):88-93. PubMed ID: 17825618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study.
    Tison F; Crochard A; Léger D; Bouée S; Lainey E; El Hasnaoui A
    Neurology; 2005 Jul; 65(2):239-46. PubMed ID: 16043793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of restless legs syndrome: a community-based study from Argentina.
    Persi GG; Etcheverry JL; Vecchi C; Parisi VL; Ayarza AC; Gatto EM
    Parkinsonism Relat Disord; 2009 Jul; 15(6):461-5. PubMed ID: 19119052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restless legs symptoms in thyroid disorders.
    Tan EK; Ho SC; Eng P; Loh LM; Koh L; Lum SY; Teoh ML; Yih Y; Khoo D
    Parkinsonism Relat Disord; 2004 Mar; 10(3):149-51. PubMed ID: 15036169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of restless legs syndrome in a rural community in Japan.
    Nomura T; Inoue Y; Kusumi M; Uemura Y; Nakashima K
    Mov Disord; 2008 Dec; 23(16):2363-9. PubMed ID: 18973260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restless legs syndrome symptoms in primary care: a prevalence study.
    Nichols DA; Allen RP; Grauke JH; Brown JB; Rice ML; Hyde PR; Dement WC; Kushida CA
    Arch Intern Med; 2003 Oct; 163(19):2323-9. PubMed ID: 14581252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
    Allen RP; Ritchie SY
    Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of unpleasant sensations in the legs: prevalence of restless legs syndrome in a primary care population.
    Möller C; Wetter TC; Köster J; Stiasny-Kolster K
    Sleep Med; 2010 Feb; 11(2):161-6. PubMed ID: 20022805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors.
    Högl B; Kiechl S; Willeit J; Saletu M; Frauscher B; Seppi K; Müller J; Rungger G; Gasperi A; Wenning G; Poewe W
    Neurology; 2005 Jun; 64(11):1920-4. PubMed ID: 15955944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restless legs syndrome in a rheumatoid arthritis patient cohort.
    Taylor-Gjevre RM; Gjevre JA; Skomro R; Nair B
    J Clin Rheumatol; 2009 Feb; 15(1):12-5. PubMed ID: 19125139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion and restless legs syndrome: a randomized controlled trial.
    Bayard M; Bailey B; Acharya D; Ambreen F; Duggal S; Kaur T; Rahman ZU; Roller K; Tudiver F
    J Am Board Fam Med; 2011; 24(4):422-8. PubMed ID: 21737767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex and the risk of restless legs syndrome in the general population.
    Berger K; Luedemann J; Trenkwalder C; John U; Kessler C
    Arch Intern Med; 2004 Jan; 164(2):196-202. PubMed ID: 14744844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restless legs syndrome prevalence and impact: REST general population study.
    Allen RP; Walters AS; Montplaisir J; Hening W; Myers A; Bell TJ; Ferini-Strambi L
    Arch Intern Med; 2005 Jun; 165(11):1286-92. PubMed ID: 15956009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.